Combined Fluoroscopy and CT Guided Radiofrequency Ablation of Thoracic Dorsal Root Ganglia in Severe Thoracic Pain
A Modified Technique of Combined Fluoroscopy and CT Guided Thermal Radiofrequency Ablation of Thoracic Dorsal Root Ganglia in Intractable Pain Associated With Thoracic Malignancies: A Randomized Clinical Trial
1 other identifier
interventional
78
1 country
1
Brief Summary
In the current study, extra-guidance other than conventional fluoroscopy - will be integrated to improve the success of the transforaminal approach to the thoracic dorsal root ganglia (DRG). The investigators hypothesize that joining CT scan with fluoroscopy to guide RF ablation through the transforaminal route may enhance its efficacy and safety in relieving the intractable pain associated with chest malignancies. The current study aimed to compare the results of thermal radiofrequency ablation (TRFA) of the thoracic DRG under combined CT and fluoroscopy guidance with the classic standard fluoroscopy technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2017
CompletedFirst Submitted
Initial submission to the registry
April 22, 2018
CompletedFirst Posted
Study publicly available on registry
May 23, 2018
CompletedMay 30, 2018
May 1, 2018
7 months
April 22, 2018
May 25, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
pain relief.
Pain intensity measured by visual analog scale (VAS).It measures the pain intensity and percentage of pain relief.The investigators used 100 mm horizontal scale with left zero end representing no pain and right 100 end representing worst pain.Scores ranging 0-39 reflect mild pain , 40-69 moderate pain and 70-100 severe pain.
12 weeks follow up
Secondary Outcomes (1)
patient satisfaction.
12 weeks
Study Arms (2)
Interventional:Combined CT-fluroscopy
ACTIVE COMPARATORCombined CT-fluroscopic radiofrequency ablation of thoracic dorsal root ganglia.
Interventional: standard fluroscopy
ACTIVE COMPARATORFluroscopic radiofrequency ablation of thoracic dorsal root ganglia.
Interventions
Radiofrequency ablation of thoracic dorsal root ganglia guided by combined CT-Fluroscopy
Radiofrequency ablation of thoracic dorsal root ganglia guided by standard fluroscopy only
Eligibility Criteria
You may qualify if:
- patients aged 18 years or more
- suffering from chronic moderate-to-severe pain ( VAS score ≥ 40 mm)
- due to malignancy involving the chest and pain was refractory to the maximally tolerated dose of opioids for at least four weeks. Malignancies included : lung cancer, pleural mesothelioma, chest wall tumors and metastatic deposits of the chest.
You may not qualify if:
- sepsis, coagulopathy
- malignant epidural invasion
- distorted local anatomy
- severe cardiorespiratory compromise
- neuropsychiatric illness
- history of drug dependence and known allergy to contrast media or the used medications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesia and Pain medicine.National Cancer Institute
Cairo, 11796, Egypt
Related Publications (1)
Reyad RM, Ghobrial HZ, Shaker EH, Reyad EM, Shaaban MH, Hashem RH, Darwish WM. Modified technique for thermal radiofrequency ablation of Thoracic dorsal root ganglia under combined fluoroscopy and CT guidance: a randomized clinical trial. BMC Anesthesiol. 2019 Dec 18;19(1):234. doi: 10.1186/s12871-019-0906-4.
PMID: 31852438DERIVED
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Ehab H Shaker, MD
National Cancer Institute- Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of anesthesia ,critical care and pain medicine
Study Record Dates
First Submitted
April 22, 2018
First Posted
May 23, 2018
Study Start
April 1, 2017
Primary Completion
October 31, 2017
Study Completion
November 30, 2017
Last Updated
May 30, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share
It will be a shared team work study during which all the investigators will have equally distributed roles.